Anavex Life Sciences Corp (AVXL)

[ClosetInvestor]

This idea of yours doesn’t sound reasonable. Why? Time and cost. You want AVXL to run an expensive, timely trial to basically rely on post-trial results to prove the efficacy of 2-73? AVXL may not have the cash to support that kind trial-extension if primary data isnt supportive enough.